BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,598,000 | +96.3% | 29,665 | +134.2% | 0.15% | +93.4% |
Q2 2022 | $814,000 | +9.7% | 12,666 | +32.3% | 0.08% | +22.6% |
Q1 2022 | $742,000 | -18.0% | 9,573 | -9.2% | 0.06% | -18.4% |
Q4 2021 | $905,000 | +32.1% | 10,538 | +23.7% | 0.08% | +11.8% |
Q3 2021 | $685,000 | +16.9% | 8,516 | +16.9% | 0.07% | +11.5% |
Q2 2021 | $586,000 | -13.4% | 7,282 | -9.3% | 0.06% | -24.7% |
Q1 2021 | $677,000 | -17.1% | 8,032 | -21.1% | 0.08% | -16.5% |
Q4 2020 | $817,000 | -37.7% | 10,185 | -37.5% | 0.10% | -33.6% |
Q3 2020 | $1,311,000 | +12.4% | 16,297 | +20.4% | 0.15% | +23.7% |
Q2 2020 | $1,166,000 | +56.9% | 13,540 | +47.9% | 0.12% | +22.9% |
Q1 2020 | $743,000 | -16.3% | 9,157 | -13.8% | 0.10% | -41.8% |
Q4 2019 | $888,000 | +93.5% | 10,624 | +102.5% | 0.16% | +52.8% |
Q3 2019 | $459,000 | +37.4% | 5,246 | +28.6% | 0.11% | +54.3% |
Q2 2019 | $334,000 | +38.0% | 4,080 | +37.1% | 0.07% | +29.6% |
Q1 2019 | $242,000 | +505.0% | 2,976 | +408.7% | 0.05% | +671.4% |
Q4 2017 | $40,000 | -7.0% | 585 | -14.0% | 0.01% | -30.0% |
Q3 2017 | $43,000 | -2.3% | 680 | -6.8% | 0.01% | 0.0% |
Q2 2017 | $44,000 | -6.4% | 730 | -17.4% | 0.01% | -16.7% |
Q1 2017 | $47,000 | -14.5% | 884 | -28.1% | 0.01% | -20.0% |
Q4 2016 | $55,000 | – | 1,230 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |